bpc-157 clinical trials humans trial safety BPC-157: What you need to know before you try The Stable Gastric Pentadecapeptide BPC

There is also a risk that, because it promotes blood vessel generation, it might also speed the growth of tumors, if the user happens to already have one

The risk groups remain consistent: people eating plant-based or low-meat diets, adults over 50, long-term users of metformin or proton pump inhibitors, anyone with GI absorption issues, people on GLP-1 protocols with significantly reduced food intake, and heavy alcohol users

Several peptides are commonly studied for their potential role in supporting healing, but BPC-157 and TB-500 are among the most frequently discussed

Protocols Dosing and schedules are set based on body weight, severity of inflammation, organ involved, and peptide pharmacology